Mindfulness-based ecological momentary intervention for smoking cessation among cancer survivors
基于正念的生态瞬时干预对癌症幸存者戒烟的影响
基本信息
- 批准号:10590358
- 负责人:
- 金额:$ 11.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-04-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:Acceptance ProcessAcuteAddressAffectAffectiveAttentionAwarenessBenchmarkingBreathingCancer CenterCancer Prevention InterventionCancer SurvivorCancer SurvivorshipCellular PhoneChronicClient satisfactionClinicalClinical TrialsCognitiveDataDevelopmentDistressEcological momentary assessmentEffectivenessElementsFatigueFeasibility StudiesFeedbackFrightFutureGeneral PopulationGoalsGuiltHealthHourIndividualInterventionInterviewKnowledgeLinkLiteratureMalignant NeoplasmsMeasuresMeditationMethodologyMissionNatureOutcomePainParticipantPatient Self-ReportPatientsPerceptionPersonsPhasePopulationPreparationProceduresProcessPsychometricsQualitative MethodsQuality of lifeRandomizedRandomized, Controlled TrialsRecording of previous eventsRecurrent Malignant NeoplasmRelapseRiskRisk FactorsRoleSecond Primary CancersSelf-ExaminationShameSmokeSmokerSmokingSmoking Cessation InterventionStressStructureSurvivorsTestingTherapeuticTimeTobaccoTobacco Use CessationTobacco useTrainingTreatment CostWorkacceptability and feasibilityanticancer researcharmbarrier to carecancer diagnosiscancer recurrencecancer therapycareercost effective interventioncravingefficacy testingexperiencefeasibility testingfollow-uphandheld mobile deviceimprovedinnovationmHealthmindfulnessmindfulness interventionmortalitynegative affectnovelpatient-level barriersportabilityprimary outcomeprototyperelapse risksatisfactionsecondary analysissmartphone applicationsmoking abstinencesmoking cessationsmoking prevalencesmoking relapsesoundstandard caretemporal measurementtobacco abstinence
项目摘要
PROJECT SUMMARY/ABSTRACT
Continued tobacco use among cancer survivors is linked to an increased risk of lowered effectiveness of cancer
treatment, greater cancer-related mortality, developing a secondary primary cancer, worse quality of life, and
increased cancer treatment costs ($3.4 billion/year). Despite high quit rates at cancer diagnosis, more than half
of survivors who quit resume smoking shortly thereafter. Mindfulness-based interventions (MBIs) hold great
promise in enhancing smoking abstinence among cancer survivors given its emphasis on purposefully paying
attention to immediate experience, thereby reducing reactivity to smoking triggers. The current proposal
addresses significant gaps in the extant smoking cessation literature for cancer survivors, which include: (1) A
limited understanding of the role of dynamic relations between cancer-specific (e.g., fatigue, pain, fear of cancer
recurrence) and general smoking risk factors (e.g., negative affect) contributing to smoking relapse given the
known chronic high stress level among cancer survivors, (2) Lack of real-time cessation interventions using
portable mobile devices such as smartphones (i.e., mobile health [mHealth]), (3) Little attention given to cancer-
specific cessation barriers for cancer survivors (e.g., shame, guilt) and (4) Barriers to treatment accessibility
among existing MBIs due to the time-intensiveness and in-person format. To address these gaps, the objective
of this proposal is to develop a mindfulness-based ecological momentary intervention (mindEMI) that delivers
MBI content in real-time and in the real world where quitting smoking takes place, and, when an elevated level
Dr.
Yang’s long-term career goal is to develop and evaluate accessible and scalable mHealth smoking cessation
interventions for cancer prevention with expertise in real-time measurement of cognitive-affective constructs. As
such, training goals address tobacco use and cancer survivorship, mHealth and clinical trials methodology,
quantitative and qualitative methods, clinical delivery of MBIs, and professional development.
of cancer-specific smoking relapse risk is indicated through ecological momentary assessment (EMA).
There are three
specific aims. The K99 phase will take place at the Moffitt Cancer Center. The aims during the K99 phase include:
(1) To identify the most psychometrically sound EMA items for measuring negative affect, positive affect, and
state mindfulness and (2) to develop a mindEMI targeting cancer-specific smoking vulnerabilities through an
iterative multi-step process among cancer survivors who smoke. The R00 phase aims to conduct a 2-arm pilot
randomized controlled trial (RCT) among cancer survivors to test the feasibility and acceptability of the mindEMI
for smoking cessation. Feasibility of RCT procedures in preparation for a larger subsequent study will also be
examined. This proposal is highly innovative because the mindEMI will address a crucial gap in the literature by
targeting cancer-specific smoking vulnerabilities and deliver an MBI in real-time when relapse risk is high for
cancer survivors. This work will inform a future trial to fully test the efficacy of mindEMI and directly addresses
the NCI’s mission to conduct and support cancer research to promote longer and healthier lives.
项目概要/摘要
癌症幸存者持续使用烟草与癌症疗效降低的风险增加有关
治疗、更高的癌症相关死亡率、发展为继发性原发性癌症、生活质量更差,以及
癌症治疗费用增加(每年 34 亿美元),尽管癌症诊断后戒烟率很高,但超过一半的人
此后不久戒烟的幸存者中基于正念的干预措施(MBI)效果很好。
鉴于其强调有目的地付费,有望提高癌症幸存者的戒烟率
关注即时经验,从而减少对吸烟触发因素的反应。
解决了现有癌症幸存者戒烟文献中的重大空白,其中包括:(1) A
对癌症特异性(例如疲劳、疼痛、对癌症的恐惧)之间的动态关系的作用了解有限
复发)和导致吸烟复发的一般吸烟危险因素(例如负面影响)
已知癌症幸存者的慢性高压力水平,(2) 缺乏使用实时戒烟干预措施
便携式移动设备,例如智能手机(即移动医疗 [mHealth]),(3) 对癌症关注甚少-
癌症幸存者的具体戒烟障碍(例如羞耻、内疚)和 (4) 获得治疗的障碍
由于时间密集和面对面的形式,现有的 MBI 之间存在差距。
该提案的目的是开发一种基于正念的生态瞬时干预(mindEMI),该干预可以提供
实时的 MBI 内容和戒烟发生的现实世界中的内容,以及当水平升高时
博士。
Yang 的长期职业目标是开发和评估可访问且可扩展的 mHealth 戒烟方法
具有实时测量认知情感结构的专业知识,进行癌症预防干预。
例如,培训目标涉及烟草使用和癌症生存、移动医疗和临床试验方法,
定量和定性方法、MBI 的临床实施以及专业发展。
癌症特异性吸烟复发风险通过生态瞬时评估(EMA)来指示。
有三个
K99 阶段将在莫菲特癌症中心进行 K99 阶段的目标包括:
(1) 确定心理测量上最合理的 EMA 项目,用于测量负面情绪、正面情绪和
陈述正念并 (2) 通过
R00 阶段旨在对吸烟的癌症幸存者进行多步骤迭代过程。
在癌症幸存者中进行的随机对照试验(RCT),以测试 MindEMI 的可行性和可接受性
为戒烟做准备的随机对照试验程序的可行性也将被确定。
该提案具有高度创新性,因为 MindEMI 将通过以下方式解决文献中的一个关键空白。
针对癌症特定的吸烟弱点,并在复发风险较高时实时提供 MBI
这项工作将为未来的试验提供信息,以全面测试 MindEMI 的功效并直接解决这一问题。
NCI 的使命是开展和支持癌症研究,以促进更长、更健康的生活。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Min-Jeong Yang其他文献
Min-Jeong Yang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
剪接因子U2AF1突变在急性髓系白血病原发耐药中的机制研究
- 批准号:82370157
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
IKZF1-N159Y/S热点突变在急性白血病中的致病机制研究
- 批准号:82300168
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
NMNAT1上调B7-H3介导急性早幼粒细胞白血病免疫逃逸的作用和机制研究
- 批准号:82300169
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
支链氨基酸转氨酶1在核心结合因子急性髓细胞白血病中的异常激活与促进白血病发生的分子机制研究
- 批准号:82370178
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
SRSF3/LRP5/Wnt信号通路在急性淋巴细胞白血病中的作用及机制研究
- 批准号:82370128
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Leveraging Community-Academic Partnerships and Social Networks to Disseminate Vaccine-Related Information and Increase Vaccine Uptake Among Black Individuals with Rheumatic Diseases
利用社区学术合作伙伴关系和社交网络传播疫苗相关信息并提高患有风湿病的黑人个体的疫苗接种率
- 批准号:
10620245 - 财政年份:2022
- 资助金额:
$ 11.88万 - 项目类别:
Leveraging Community-Academic Partnerships and Social Networks to Disseminate Vaccine-Related Information and Increase Vaccine Uptake Among Black Individuals with Rheumatic Diseases
利用社区学术合作伙伴关系和社交网络传播疫苗相关信息并提高患有风湿病的黑人个体的疫苗接种率
- 批准号:
10442270 - 财政年份:2022
- 资助金额:
$ 11.88万 - 项目类别:
Leveraging Community-Academic Partnerships and Social Networks to Disseminate Vaccine-Related Information and Increase Vaccine Uptake Among Black Individuals with Rheumatic Diseases
利用社区学术合作伙伴关系和社交网络传播疫苗相关信息并提高患有风湿病的黑人个体的疫苗接种率
- 批准号:
10442270 - 财政年份:2022
- 资助金额:
$ 11.88万 - 项目类别:
A multidimensional Digital Approach to Address Vaccine Hesitancy and Increase COVID-19 Vaccine Uptake among African American Young Adults in the South
解决疫苗犹豫问题并提高南方非裔美国年轻人对 COVID-19 疫苗接种率的多维数字方法
- 批准号:
10336591 - 财政年份:2021
- 资助金额:
$ 11.88万 - 项目类别: